Report Detail

Electronics & Semiconductor Global 3D Microfluidic Organ Chip Market Growth 2022-2028

  • RnM4489495
  • |
  • 06 September, 2022
  • |
  • Global
  • |
  • 103 Pages
  • |
  • LPI(LP Information)
  • |
  • Electronics & Semiconductor

The global market for 3D Microfluidic Organ Chip is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

The APAC 3D Microfluidic Organ Chip market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The United States 3D Microfluidic Organ Chip market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The Europe 3D Microfluidic Organ Chip market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The China 3D Microfluidic Organ Chip market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

Global key 3D Microfluidic Organ Chip players cover Emulate, TissUse, Hesperos, CN Bio Innovations and Tara Biosystems, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

Report Coverage
This latest report provides a deep insight into the global 3D Microfluidic Organ Chip market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.

This report aims to provide a comprehensive picture of the global 3D Microfluidic Organ Chip market, with both quantitative and qualitative data, to help readers understand how the 3D Microfluidic Organ Chip market scenario changed across the globe during the pandemic and Russia-Ukraine War.

The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.

Market Segmentation:
The study segments the 3D Microfluidic Organ Chip market and forecasts the market size by Type (Brain-on-a-chip, Liver-on-a-chip and Kidney-on-a-chip), by Application (Hospital, Biotechnology and Others,), and region (APAC, Americas, Europe, and Middle East & Africa).

Segmentation by type
Brain-on-a-chip
Liver-on-a-chip
Kidney-on-a-chip
Others

Segmentation by application
Hospital
Biotechnology
Others

Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

Major companies covered
Emulate
TissUse
Hesperos
CN Bio Innovations
Tara Biosystems
Draper Laboratory
Mimetas
Nortis
Micronit Microtechnologies B.V.
Kirkstall
Cherry Biotech SAS
Else Kooi Laboratory

Chapter Introduction
Chapter 1: Scope of 3D Microfluidic Organ Chip, Research Methodology, etc.
Chapter 2: Executive Summary, global 3D Microfluidic Organ Chip market size (sales and revenue) and CAGR, 3D Microfluidic Organ Chip market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: 3D Microfluidic Organ Chip sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global 3D Microfluidic Organ Chip sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global 3D Microfluidic Organ Chip market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Emulate, TissUse, Hesperos, CN Bio Innovations, Tara Biosystems, Draper Laboratory, Mimetas, Nortis and Micronit Microtechnologies B.V., etc.
Chapter 14: Research Findings and Conclusion


Scope of the Report

  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered

2 Executive Summary

  • 2.1 World Market Overview
    • 2.1.1 Global 3D Microfluidic Organ Chip Annual Sales 2017-2028
    • 2.1.2 World Current & Future Analysis for 3D Microfluidic Organ Chip by Geographic Region, 2017, 2022 & 2028
    • 2.1.3 World Current & Future Analysis for 3D Microfluidic Organ Chip by Country/Region, 2017, 2022 & 2028
  • 2.2 3D Microfluidic Organ Chip Segment by Type
    • 2.2.1 Brain-on-a-chip
    • 2.2.2 Liver-on-a-chip
    • 2.2.3 Kidney-on-a-chip
    • 2.2.4 Others
  • 2.3 3D Microfluidic Organ Chip Sales by Type
    • 2.3.1 Global 3D Microfluidic Organ Chip Sales Market Share by Type (2017-2022)
    • 2.3.2 Global 3D Microfluidic Organ Chip Revenue and Market Share by Type (2017-2022)
    • 2.3.3 Global 3D Microfluidic Organ Chip Sale Price by Type (2017-2022)
  • 2.4 3D Microfluidic Organ Chip Segment by Application
    • 2.4.1 Hospital
    • 2.4.2 Biotechnology
    • 2.4.3 Others
  • 2.5 3D Microfluidic Organ Chip Sales by Application
    • 2.5.1 Global 3D Microfluidic Organ Chip Sale Market Share by Application (2017-2022)
    • 2.5.2 Global 3D Microfluidic Organ Chip Revenue and Market Share by Application (2017-2022)
    • 2.5.3 Global 3D Microfluidic Organ Chip Sale Price by Application (2017-2022)

3 Global 3D Microfluidic Organ Chip by Company

  • 3.1 Global 3D Microfluidic Organ Chip Breakdown Data by Company
    • 3.1.1 Global 3D Microfluidic Organ Chip Annual Sales by Company (2020-2022)
    • 3.1.2 Global 3D Microfluidic Organ Chip Sales Market Share by Company (2020-2022)
  • 3.2 Global 3D Microfluidic Organ Chip Annual Revenue by Company (2020-2022)
    • 3.2.1 Global 3D Microfluidic Organ Chip Revenue by Company (2020-2022)
    • 3.2.2 Global 3D Microfluidic Organ Chip Revenue Market Share by Company (2020-2022)
  • 3.3 Global 3D Microfluidic Organ Chip Sale Price by Company
  • 3.4 Key Manufacturers 3D Microfluidic Organ Chip Producing Area Distribution, Sales Area, Product Type
    • 3.4.1 Key Manufacturers 3D Microfluidic Organ Chip Product Location Distribution
    • 3.4.2 Players 3D Microfluidic Organ Chip Products Offered
  • 3.5 Market Concentration Rate Analysis
    • 3.5.1 Competition Landscape Analysis
    • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
  • 3.6 New Products and Potential Entrants
  • 3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for 3D Microfluidic Organ Chip by Geographic Region

  • 4.1 World Historic 3D Microfluidic Organ Chip Market Size by Geographic Region (2017-2022)
    • 4.1.1 Global 3D Microfluidic Organ Chip Annual Sales by Geographic Region (2017-2022)
    • 4.1.2 Global 3D Microfluidic Organ Chip Annual Revenue by Geographic Region
  • 4.2 World Historic 3D Microfluidic Organ Chip Market Size by Country/Region (2017-2022)
    • 4.2.1 Global 3D Microfluidic Organ Chip Annual Sales by Country/Region (2017-2022)
    • 4.2.2 Global 3D Microfluidic Organ Chip Annual Revenue by Country/Region
  • 4.3 Americas 3D Microfluidic Organ Chip Sales Growth
  • 4.4 APAC 3D Microfluidic Organ Chip Sales Growth
  • 4.5 Europe 3D Microfluidic Organ Chip Sales Growth
  • 4.6 Middle East & Africa 3D Microfluidic Organ Chip Sales Growth

5 Americas

  • 5.1 Americas 3D Microfluidic Organ Chip Sales by Country
    • 5.1.1 Americas 3D Microfluidic Organ Chip Sales by Country (2017-2022)
    • 5.1.2 Americas 3D Microfluidic Organ Chip Revenue by Country (2017-2022)
  • 5.2 Americas 3D Microfluidic Organ Chip Sales by Type
  • 5.3 Americas 3D Microfluidic Organ Chip Sales by Application
  • 5.4 United States
  • 5.5 Canada
  • 5.6 Mexico
  • 5.7 Brazil

6 APAC

  • 6.1 APAC 3D Microfluidic Organ Chip Sales by Region
    • 6.1.1 APAC 3D Microfluidic Organ Chip Sales by Region (2017-2022)
    • 6.1.2 APAC 3D Microfluidic Organ Chip Revenue by Region (2017-2022)
  • 6.2 APAC 3D Microfluidic Organ Chip Sales by Type
  • 6.3 APAC 3D Microfluidic Organ Chip Sales by Application
  • 6.4 China
  • 6.5 Japan
  • 6.6 South Korea
  • 6.7 Southeast Asia
  • 6.8 India
  • 6.9 Australia
  • 6.10 China Taiwan

7 Europe

  • 7.1 Europe 3D Microfluidic Organ Chip by Country
    • 7.1.1 Europe 3D Microfluidic Organ Chip Sales by Country (2017-2022)
    • 7.1.2 Europe 3D Microfluidic Organ Chip Revenue by Country (2017-2022)
  • 7.2 Europe 3D Microfluidic Organ Chip Sales by Type
  • 7.3 Europe 3D Microfluidic Organ Chip Sales by Application
  • 7.4 Germany
  • 7.5 France
  • 7.6 UK
  • 7.7 Italy
  • 7.8 Russia

8 Middle East & Africa

  • 8.1 Middle East & Africa 3D Microfluidic Organ Chip by Country
    • 8.1.1 Middle East & Africa 3D Microfluidic Organ Chip Sales by Country (2017-2022)
    • 8.1.2 Middle East & Africa 3D Microfluidic Organ Chip Revenue by Country (2017-2022)
  • 8.2 Middle East & Africa 3D Microfluidic Organ Chip Sales by Type
  • 8.3 Middle East & Africa 3D Microfluidic Organ Chip Sales by Application
  • 8.4 Egypt
  • 8.5 South Africa
  • 8.6 Israel
  • 8.7 Turkey
  • 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities
  • 9.2 Market Challenges & Risks
  • 9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

  • 10.1 Raw Material and Suppliers
  • 10.2 Manufacturing Cost Structure Analysis of 3D Microfluidic Organ Chip
  • 10.3 Manufacturing Process Analysis of 3D Microfluidic Organ Chip
  • 10.4 Industry Chain Structure of 3D Microfluidic Organ Chip

11 Marketing, Distributors and Customer

  • 11.1 Sales Channel
    • 11.1.1 Direct Channels
    • 11.1.2 Indirect Channels
  • 11.2 3D Microfluidic Organ Chip Distributors
  • 11.3 3D Microfluidic Organ Chip Customer

12 World Forecast Review for 3D Microfluidic Organ Chip by Geographic Region

  • 12.1 Global 3D Microfluidic Organ Chip Market Size Forecast by Region
    • 12.1.1 Global 3D Microfluidic Organ Chip Forecast by Region (2023-2028)
    • 12.1.2 Global 3D Microfluidic Organ Chip Annual Revenue Forecast by Region (2023-2028)
  • 12.2 Americas Forecast by Country
  • 12.3 APAC Forecast by Region
  • 12.4 Europe Forecast by Country
  • 12.5 Middle East & Africa Forecast by Country
  • 12.6 Global 3D Microfluidic Organ Chip Forecast by Type
  • 12.7 Global 3D Microfluidic Organ Chip Forecast by Application

13 Key Players Analysis

  • 13.1 Emulate
    • 13.1.1 Emulate Company Information
    • 13.1.2 Emulate 3D Microfluidic Organ Chip Product Offered
    • 13.1.3 Emulate 3D Microfluidic Organ Chip Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.1.4 Emulate Main Business Overview
    • 13.1.5 Emulate Latest Developments
  • 13.2 TissUse
    • 13.2.1 TissUse Company Information
    • 13.2.2 TissUse 3D Microfluidic Organ Chip Product Offered
    • 13.2.3 TissUse 3D Microfluidic Organ Chip Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.2.4 TissUse Main Business Overview
    • 13.2.5 TissUse Latest Developments
  • 13.3 Hesperos
    • 13.3.1 Hesperos Company Information
    • 13.3.2 Hesperos 3D Microfluidic Organ Chip Product Offered
    • 13.3.3 Hesperos 3D Microfluidic Organ Chip Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.3.4 Hesperos Main Business Overview
    • 13.3.5 Hesperos Latest Developments
  • 13.4 CN Bio Innovations
    • 13.4.1 CN Bio Innovations Company Information
    • 13.4.2 CN Bio Innovations 3D Microfluidic Organ Chip Product Offered
    • 13.4.3 CN Bio Innovations 3D Microfluidic Organ Chip Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.4.4 CN Bio Innovations Main Business Overview
    • 13.4.5 CN Bio Innovations Latest Developments
  • 13.5 Tara Biosystems
    • 13.5.1 Tara Biosystems Company Information
    • 13.5.2 Tara Biosystems 3D Microfluidic Organ Chip Product Offered
    • 13.5.3 Tara Biosystems 3D Microfluidic Organ Chip Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.5.4 Tara Biosystems Main Business Overview
    • 13.5.5 Tara Biosystems Latest Developments
  • 13.6 Draper Laboratory
    • 13.6.1 Draper Laboratory Company Information
    • 13.6.2 Draper Laboratory 3D Microfluidic Organ Chip Product Offered
    • 13.6.3 Draper Laboratory 3D Microfluidic Organ Chip Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.6.4 Draper Laboratory Main Business Overview
    • 13.6.5 Draper Laboratory Latest Developments
  • 13.7 Mimetas
    • 13.7.1 Mimetas Company Information
    • 13.7.2 Mimetas 3D Microfluidic Organ Chip Product Offered
    • 13.7.3 Mimetas 3D Microfluidic Organ Chip Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.7.4 Mimetas Main Business Overview
    • 13.7.5 Mimetas Latest Developments
  • 13.8 Nortis
    • 13.8.1 Nortis Company Information
    • 13.8.2 Nortis 3D Microfluidic Organ Chip Product Offered
    • 13.8.3 Nortis 3D Microfluidic Organ Chip Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.8.4 Nortis Main Business Overview
    • 13.8.5 Nortis Latest Developments
  • 13.9 Micronit Microtechnologies B.V.
    • 13.9.1 Micronit Microtechnologies B.V. Company Information
    • 13.9.2 Micronit Microtechnologies B.V. 3D Microfluidic Organ Chip Product Offered
    • 13.9.3 Micronit Microtechnologies B.V. 3D Microfluidic Organ Chip Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.9.4 Micronit Microtechnologies B.V. Main Business Overview
    • 13.9.5 Micronit Microtechnologies B.V. Latest Developments
  • 13.10 Kirkstall
    • 13.10.1 Kirkstall Company Information
    • 13.10.2 Kirkstall 3D Microfluidic Organ Chip Product Offered
    • 13.10.3 Kirkstall 3D Microfluidic Organ Chip Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.10.4 Kirkstall Main Business Overview
    • 13.10.5 Kirkstall Latest Developments
  • 13.11 Cherry Biotech SAS
    • 13.11.1 Cherry Biotech SAS Company Information
    • 13.11.2 Cherry Biotech SAS 3D Microfluidic Organ Chip Product Offered
    • 13.11.3 Cherry Biotech SAS 3D Microfluidic Organ Chip Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.11.4 Cherry Biotech SAS Main Business Overview
    • 13.11.5 Cherry Biotech SAS Latest Developments
  • 13.12 Else Kooi Laboratory
    • 13.12.1 Else Kooi Laboratory Company Information
    • 13.12.2 Else Kooi Laboratory 3D Microfluidic Organ Chip Product Offered
    • 13.12.3 Else Kooi Laboratory 3D Microfluidic Organ Chip Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.12.4 Else Kooi Laboratory Main Business Overview
    • 13.12.5 Else Kooi Laboratory Latest Developments

14 Research Findings and Conclusion

Summary:
Get latest Market Research Reports on 3D Microfluidic Organ Chip. Industry analysis & Market Report on 3D Microfluidic Organ Chip is a syndicated market report, published as Global 3D Microfluidic Organ Chip Market Growth 2022-2028. It is complete Research Study and Industry Analysis of 3D Microfluidic Organ Chip market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

Last updated on

REPORT YOU MIGHT BE INTERESTED

Purchase this Report

$3,660.00
$7,320.00
3,407.46
6,814.92
3,806.40
7,612.80
528,321.00
1,056,642.00
298,326.60
596,653.20
Credit card Logo

Related Reports


Reason to Buy

Request for Sample of this report